Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Heat Biologics (HTBX) Presents at Rodman & Renshaw Conference

Heat Biologics, Inc. (NASDAQ: HTBX) is leading the immuno-oncology revolution. A clinical-stage company, Heat Biologics focuses on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell-based immunotherapy to treat patients with a wide array of cancers and infectious diseases. Heat Biologics’ ImPACT Immunotherapy transforms living allogeneic human cancer cells into miniature osmotic pumps that continually secrete cancer antigens to activate a patient’s own immune system in order to destroy the cancer cells. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.